History

2026
- Launch of gut microbiome analysis services and the personalized probiotics brand 'U2Biome'
- Renamed to U2XLab Co., Ltd.
2025
- Awarded the Prime Minister's Commendation for Outstanding Family-Friendly Management
2024
- Expansion of clinical trial analysis scope with additional designation for Nucleic Acid Analysis and Clinical Testing
- Expansion of clinical trial analysis scope with additional designation for Two-way crossover pharmacokinetic study
- Launch of specialized analysis services for Alzheimer's disease therapeutics
2023
- Certification as a Hi-Seoul Enterprise
- Expansion of the specialized LC-MS/MS center
2022
- Certification as a MAIN-Biz (Management Innovation Business)
2021
- Expansion of the Bioanalytical Service Laboratory
- Acquisition of the CAP certification for FACS Proficiency Testing (PT)
- Establishment of the Corporate R&D Center
2020
- Renamed to SML Meditree Co., Ltd.
2019
- Designation as a Good Clinical Laboratory Practice (GCLP) facility by the MFDS
2016
- Acquisition of ISO 9001 (Quality Management System) and ISO 14001 (Environmental Management System) certifications
2014
- Establishment of a dedicated analytical laboratory for clinical trials
2012
- Establishment of Meditree Co., Ltd. (Spun off from Samkwang Medical Laboratories)

U2XLab, Your Analytical Partner for R&D Success

Contact Us